Oncology Institute (DFPH) Acquisitions (2021 - 2023)

Oncology Institute (DFPH) has reported Acquisitions for 3 consecutive years, with $156000.0 the latest figure, recorded in Q4 2023.

• Acquisitions for Q4 2023 came in at $156000.0, down 66.81% year-over-year; the trailing twelve-month figure through Dec 2024 was $156000.0 (up 183.42% YoY), and the FY2023 annual result was $4.5 million, down 48.05% from the prior year.
• Acquisitions was $156000.0 for Q4 2023 at Oncology Institute, down from $470000.0 in the prior quarter.
• Over five years, Acquisitions peaked at $8.9 million in Q2 2022 and troughed at -$813000.0 in Q3 2022.
• Average Acquisitions over 3 years is $3.0 million, with a median of $648500.0 recorded in 2021.
• Year-over-year, Acquisitions sank 94.32% in 2022 and tumbled 66.81% in 2023.
• Over 3 years, Acquisitions stood at $8.3 million in 2021, then tumbled by 94.32% to $470000.0 in 2022, then sank by 66.81% to $156000.0 in 2023.
• Per Business Quant data, the three most recent Acquisitions figures were $156000.0 in Q4 2023, $470000.0 in Q4 2022, and -$813000.0 in Q3 2022.